Brilliant insights from Tom Powles Barts Cancer Institute (Queen Mary). Excellent use of Twitter polls to reconcile tough clinical scenarios (eg IO rechallenge following adj pembro). Shocking to hear rates of IO receipt in real world series - great point from Tom - use the best tx first. Toni Choueiri, MD

Thanks to JAMA Internal Medicine for publishing my story about two patient encounters as an ICU resident with Cleveland Clinic IM which served as important lessons in communication that I will never forget. Grateful to their families for letting me tell these stories jamanetwork.com/journals/jamai…

🎉Excited to announce my promotion to Professor Cleveland Clinic MD CWRU School of Medicine Grateful to my family, friends & colleagues for believing in me & supporting me. Special thx to my incredible boys, Arash & Arav who have been my rock through it all! Jame Abraham, MD, FACP Moffitt Cancer Center UMN Medical School

#TiNivo2 results are out —adding PD1 inhibitor nivolumab simply does not help after rechallenge /progression on prior immunotherapy. Time to follow level 1 evidence! PRNEWS Targeted Oncology OncLive.com KidneyCAN Kidney Cancer Uromigos Oncology Brothers —implications beyond renal cancer ?

Just finished this incredible book by Gila Pfeffer (as in ‘Hava Nagila’) Nearly Departed: Adventures in Loss, Cancer, and Other Inconveniences. Incredible personal account of a someone with a strong cancer history, BRCA+, and the steps taken to protect herself and her family. shorturl.at/e5D7P

Hi folks - our lab in Dana-Farber Division of Population Sciences has an opening for a post-doctoral fellow at the interface of prostate cancer and AI via collab. with Dr. Mary-Ellen Taplin + Dana-Farber Lank Center for Genitourinary Oncology - link below! careers.dana-farber.org/job/10110/post… Dana-Farber Broad Institute Harvard Medical School

Rly excited to share this ASCO piece in my new series "Profiles in Advocacy " highlighting Oncologists from all over the U.S. Here's Dr Najera's story who I met at #ASCOadvocacysummit Yes community oncology voices matter connection.asco.org/blogs/profiles… Ashley Love Sumrall, MD, FACP, FASCO Jason Westin, MD FACP

"My journey with Tim Gilligan, Chris Weight and all the other members of this exploration team through unchartered waters is exciting. I’ve been very lucky with respect to the people I’ve traveled with.” #CleClinicCancer Climb4KidneyCancer tinyurl.com/yrf9fyje

Incredible amount of work and dedication went into our Cystectomy book Cleveland Clinic Urology by the whole team including Rebecca Campbell Nima Almassi Chris Weight .. it’s the absolute best resource and we are so excited to hopefully share it everyone soon! #BCANTT24

Great interview by Chris Weight Cleveland Clinic Urology on the Climb 4 Kidney Cancer Climb4KidneyCancer event this weekend. Still time to register and donate as celebrate our #kidneycancer patients and research #RCC give.ccf.org/team/585396 youtube.com/watch?v=CfK-UR…

1/ 🚨 Just in European Urology , our study on first-line systemic therapy following adjuvant immunotherapy in renal cell carcinoma. Effort co-led with Talal El Zarif, MD, with amazing mentorship from Daniel Heng Toni Choueiri, MD sciencedirect.com/science/articl… Dana-Farber Lank Center for Genitourinary Oncology Yale School of Medicine OncoAlert

Lab website up and running!!! Soon to add a post doc and a tech along with our new research coordinator . Amazing things are happening #microbiome could not do any of this without support from Timothy Chan and Chris Weight Cleveland Clinic Urology Cleveland Clinic Lerner Research Institute lerner.ccf.org/immunotherapy/… #fmt

Abstracts extended! Submit here kidneycancer.swoogo.com/IKCSNA24/cfs/5… This is an amazing meeting and hope to see the Kidney Cancer Community in Louisville in Nov! Yousef Zakharia Sarah P. Psutka MD MS Qing Zhang Tian Zhang, MD, MHS Phillip Pierorazio Brian Rini, MD #IKCSNA24

Jason Brown JAGarciaMD Arnab Basu Eric A. Singer, MD, MA, MS, FACS, FASCO Toni Choueiri, MD Tian Zhang, MD, MHS Moshe Ornstein MD Andrea Apolo, M.D. 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 Bryan Lewis Romualdo Barroso, MD PhD Enrique Grande Elizabeth Plimack MD Dan George

Congrats to Moshe Ornstein MD and team for demonstrating the feasibility of an intermittent ipi/nivo approach in their Phase II trial, showing potential for prolonged treatment-free intervals. 🌟📊 Looking forward to more studies like this! #RCC clinical-genitourinary-cancer.com/article/S1558-…

Important dose optimization for belzutifan — 120mg is sufficient! Kidney Cancer KCCure KidneyCAN

Chance to work with some great GU oncologists! 👇

NIAGRA presented #ESMO24 and published today NEJM – huge accomplishment 1000+ patients enrolled. Exciting results! Some thoughts on applying them to practice...

The RCC TiNivo-2 study may have been overall negative, but it highlighted: 1️⃣ CKI shouldn’t continue in IO-refractory disease. 2️⃣ Selective VEGF TKIs like tivozanib can have activity in the post-IO setting. 3️⃣ TKI dosage matters. #RCC #ESMO24 #TiNivo2